🇺🇸 Alcaftadine 0.25% in United States

FDA authorised Alcaftadine 0.25% on 28 July 2010

Marketing authorisations

FDA — authorised 28 July 2010

  • Application: NDA022134
  • Marketing authorisation holder: ABBVIE
  • Local brand name: LASTACAFT
  • Indication: SOLUTION/DROPS — OPHTHALMIC
  • Status: approved

Read official source →

FDA

  • Status: approved

Alcaftadine 0.25% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Alcaftadine 0.25% approved in United States?

Yes. FDA authorised it on 28 July 2010; FDA has authorised it.

Who is the marketing authorisation holder for Alcaftadine 0.25% in United States?

ABBVIE holds the US marketing authorisation.